Examination of the usefulness for the treatment of ulcerative colitis through the change of enterobacterial flora derived by adacolumn treatment.
- Conditions
- ulcerative colitis
- Registration Number
- JPRN-UMIN000017179
- Lead Sponsor
- Kyoto Prefectural University of Medicine, Department of Molecular Gastroenterology and Hepatology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Not provided
a) The re-registration patients for this study b) The number of granulocyte is under 2,000/mm3 c) A patient complicated with a serious infectious disease d) Patient with a serious heart trouble e) Patient with a serious renal trouble f) Patient with low blood pressure (maximum pressure is under 80mmHg) g) Patient with pregnancy h) Strength sthenia pro-extreme dehydration, solidification, patient of serious anemia (less than 8.0 g/dL of hemoglobin) i) Patient with malignant tumor j) Patient with stoma k) Patient who had surgery for intestine with 12 weeks l) Patient with serious complications out of intestinal tract m) Patient who had GMA treatment within 4 weeks n) Patient who had started or increased thiopurine within 8 weeks o) The patient who judged an arrangement to the final examination if the medical attendant was inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The relationship between the change of enterobacterial flora and improvement of endoscopic finding, clinical symptoms.
- Secondary Outcome Measures
Name Time Method The change of inflammatory related gene expression in colonic mucosa after GMA treatment.